thumbnail
Artificial IntelligenceQuest Finds its Path to AI in Cancer Diagnostics Through M&AQuest Diagnostics in Plan to Acquire PathAI’s Assets
The deal follows Labcorp, Quest’s rival, becoming the winning bidder to acquire Invitae’s assets.
Sign up for the QMED & MD+DI Daily newsletter.